1994
DOI: 10.1093/hmg/3.7.1203
|View full text |Cite
|
Sign up to set email alerts
|

Three novel rhodopsin mutations (C110F, L131P, A164V) in patients with autosomal dominant retinitis pigmentosa

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
15
0

Year Published

1996
1996
2017
2017

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 26 publications
(16 citation statements)
references
References 0 publications
1
15
0
Order By: Relevance
“…34,35 Disease-causing mutations of the highly conserved disulfide bond connecting ECL1 and ECL2 have been identified in many GPCRs, including AVPR2, 36 RHO 37,38 and MC2R. 39 About 7% of all missense mutations in GPCR are substitutions with cysteine residues found in the putative N-terminal portion and ECL1-3.…”
Section: Discussionmentioning
confidence: 99%
“…34,35 Disease-causing mutations of the highly conserved disulfide bond connecting ECL1 and ECL2 have been identified in many GPCRs, including AVPR2, 36 RHO 37,38 and MC2R. 39 About 7% of all missense mutations in GPCR are substitutions with cysteine residues found in the putative N-terminal portion and ECL1-3.…”
Section: Discussionmentioning
confidence: 99%
“…This result paralleled the earlier findings on the small-protein bovine pancreatic trypsin inhibitor, and, by analogy, suggested a globular structure for the intradiscal domain in rhodopsin (3). Recently, point mutations at the intradiscal cysteines (C110F, C110Y, and C187Y) in rhodopsin associated with RP have been discovered (14)(15)(16)(17) and, in addition, mutation of a conserved cysteine equivalent to Cys-187 in cone opsins (C203R) has been shown to cause color vision deficiencies (18,19).…”
mentioning
confidence: 99%
“…We show by kinetic studies of retinal binding that the mutants show large variation in rates of retinal binding. We have chosen as examples the tryptophan 265 mutants, W265F,Y,A (7), as well as the retinitis pigmentosa (RP) mutant A164V (9,10) in the transmembrane domain (Fig. 1).…”
mentioning
confidence: 99%